🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT05570929
Recruiting Observational

LONGitudinal Multi-omics Phenotyping of KIDney Function Alteration

NCT05570929 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2023-02-07
Last updated
2024-07-01

Condition(s) studied

Chronic Kidney Diseases

Study summary

This is a longitudinal observation of kidney function, immune system and gut microbiota before and 24 weeks after a live kidney transplantation conducted in donor and recipient pairs living in the same household. Outcome measures include kidney function, body composition, blood pressure, gut microbiome composition, metabolomics and immune cell states.

Eligibility

Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Body-Mass-Index 18,5 - 34,9 kg/m2 * Planned living kidney donation / transplantation Exclusion Criteria: * Clinically relevant heart, lung, liver, and kidney diseases * Postoperative phase * Acute infections * Vegan diet * Change of body weight of more than 10% in the month prior to study entry * Known drug or alcohol abuse

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Experimental and Clinical Research Center Berlin Germany Recruiting

More Charite University, Berlin, Germany trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05570929 on ClinicalTrials.gov ↗ ← All trials in Germany